DiaSorin stock trades at EUR 76.32 as buyback reaches EUR 250 million

Published on 10/18/2026 at 17:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DiaSorin stock trades at EUR 76.32 in weekend trading on October 18, 2026. The company completed its EUR 250 million buyback on October 7.

Buyback and trading context

On October 7, 2026, DiaSorin completed a EUR 250 million share buyback program.
DiaSorin stock traded at EUR 76.32 at 5:02 p.m. CEST at Lang & Schwarz on October 18, 2026.
The next Xetra session is scheduled for October 19, 2026.

Techniker im Reinraum bedienen automatisierte Diagnostikgeräte in modernem Biotech-Labor — Modernes Diagnostiklabor von DiaSorin S.p.A., ISIN IT0003497168, zeigt präzise Biotech-Produktion und klinische Fertigung, Illustration mit AI erstellt.

On October 7, 2026, DiaSorin announced the completion of its share buyback program, which involved aggregate purchases of 3,790,952 shares for EUR 249,999,986.67. DiaSorin stock traded at EUR 76.32 at Lang & Schwarz at 5:02 p.m. CEST on October 18, 2026.

The week in figures

Lang & Schwarz recorded a weekend-trading price of EUR 76.32 for DiaSorin at 5:02 p.m. CEST on October 18, 2026. The quote showed a bid of EUR 76.28 and an ask of EUR 76.36.

The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of DiaSorin stock.

Buyback completion

The company said its program was authorized by the Shareholders’ Meeting on January 27, 2026 and was aimed at canceling the purchased shares without reducing share capital. The program allowed maximum spending of EUR 250 million and purchases of no more than 4.5 million shares. As of October 5, 2026, DiaSorin held 6,683,050 treasury shares, equal to 11.95 percent of share capital, according to the company announcement.

Market context: Market report FTSE MIB.